Syndrome of inappropriate antidiuretic hormone secretion following irinotecan-cisplatin administration as a treatment for recurrent ovarian clear cell carcinoma
Do Youn Kwon, Gwan Hee Han, Roshani Ulak, Kyung Do Ki, Jong Min Lee, Seon Kyung Lee
Obstet Gynecol Sci. 2017;60(1):115-117.   Published online 2017 Jan 19     DOI: https://doi.org/10.5468/ogs.2017.60.1.115
Citations to this article as recorded by Crossref logo
Electrolyte Disorders Induced by Antineoplastic Drugs
Ignazio Verzicco, Giuseppe Regolisti, Federico Quaini, Pietro Bocchi, Irene Brusasco, Massimiliano Ferrari, Giovanni Passeri, Valentina Cannone, Pietro Coghi, Enrico Fiaccadori, Alessandro Vignali, Riccardo Volpi, Aderville Cabassi
Frontiers in Oncology.2020;[Epub]     CrossRef
Peripherally administered cisplatin activates a parvocellular neuronal subtype expressing arginine vasopressin and enhanced green fluorescent protein in the paraventricular nucleus of a transgenic rat
Yasuki Akiyama, Mitsuhiro Yoshimura, Hiromichi Ueno, Kenya Sanada, Kentaro Tanaka, Satomi Sonoda, Haruki Nishimura, Kazuaki Nishimura, Yasuhito Motojima, Reiko Saito, Takashi Maruyama, Keiji Hirata, Yasuhito Uezono, Yoichi Ueta
The Journal of Physiological Sciences.2020;[Epub]     CrossRef
Risk Factors for Severe Hyponatremia Related to Cisplatin: A Retrospective Case-Control Study
Shiro Hatakeyama, Toshihiro Shida, Hiroaki Yamaguchi
Biological and Pharmaceutical Bulletin.2019; 42(11): 1891.     CrossRef
Capn4 regulates migration and invasion of ovarian carcinoma cells via targeting osteopontin‑mediated PI3K/AKT signaling pathway
Yuanyuan Chen, Gang Wang, Yingmei Wang, Xiaoli Gao, Kan Wang, Jie Li, Fengxia Xue
Oncology Letters.2018;[Epub]     CrossRef